Form 8-K - Current report:
SEC Accession No. 0001493152-25-014240
Filing Date
2025-09-19
Accepted
2025-09-19 16:05:48
Documents
12
Period of Report
2025-09-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 33532
  Complete submission text file 0001493152-25-014240.txt   198004

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE imdx-20250916.xsd EX-101.SCH 3011
3 XBRL LABEL FILE imdx-20250916_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE imdx-20250916_pre.xml EX-101.PRE 22356
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3692
Mailing Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217
Business Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217 949-409-7600
Insight Molecular Diagnostics Inc. (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 251326877
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)